|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.22 USD | +0.26% |
|
+0.75% | +20.76% |
| 06:03am | South Africa seeks local production of Gilead's HIV prevention drug | RE |
| 03-03 | Gilead Sciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:10 AM |
Chart calendar Gilead Sciences, Inc.
Upcoming events on Gilead Sciences, Inc.
| 13/03/2026 | Ex-dividend date - 0.82 USD | 04:00 |
| 24/04/2026 | Estimated Earnings Release Date (S&P Global Derived) - Q1 2026 | ~ 21:00 |
Past events on Gilead Sciences, Inc.
| 10/02/2026 | Earnings presentation | 21:30 |
| 10/02/2026 | Earnings release - Q4 2025 | ~ 21:00 |
| 30/10/2025 | Earnings presentation | 20:30 |
| 30/10/2025 | Earnings release - Q3 2025 | ~ 20:00 |
| 07/08/2025 | Earnings presentation | 21:30 |
| 07/08/2025 | Earnings release - Q2 2025 | ~ 21:00 |
| 07/05/2025 | Présentation aux Actionnaires / Analystes | 18:00 |
| 07/05/2025 | Annual General Meeting | Day |
| 24/04/2025 | Earnings presentation | 21:30 |
| 24/04/2025 | Earnings release - Q1 2025 | ~ 21:00 |
Past dividends on Gilead Sciences, Inc.
| 15/12/2025 | Ex-dividend date - 0.79 USD | 05:00 |
| 15/09/2025 | Ex-dividend date - 0.79 USD | 05:00 |
| 13/06/2025 | Ex-dividend date - 0.79 USD | 05:00 |
| 14/03/2025 | Ex-dividend date - 0.79 USD | 04:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27 116 27 083 0.12% | 28 754 28 310 1.57% | 29 443 29 203 0.82% | 30 188 | 32 045 | 33 627 |
|
EBITDA Million USD | Released Forecast Spread | 13 177 13 123 0.41% | 11 287 10 600 6.49% | 15 953 15 971 -0.11% | 16 688 | 17 771 | 19 905 |
|
EBIT Million USD | Released Forecast Spread | 10 484 10 687 -1.9% | 8 520 8 238 3.42% | 13 193 13 218 -0.19% | 14 175 | 15 575 | 16 699 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 859 7 323 -6.33% | 690 498 38.57% | 9 796 10 031 -2.34% | 10 624 | 11 656 | 12 850 |
|
Net income Million USD | Released Forecast Spread | 5 665 5 872 -3.52% | 480 282 70.44% | 8 510 8 235 3.34% | 8 978 | 9 911 | 10 824 |
|
EPS USD | Released Forecast Spread | 4,50 4,69 -3.96% | 0,38 0,10 274.46% | 6,78 6,82 -0.56% | 7,21 | 8,33 | 8,86 |
| Announcement Date | 06/02/24 | 11/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 954 6 735 3.25% | 7 545 6 999 7.8% | 7 569 7 154 5.8% | 6 667 6 823 -2.29% | 7 082 6 964 1.69% | 7 769 7 459 4.16% | 7 925 7 678 3.21% | 6 923 | 7 412 | 7 728 | 8 177 | 7 283 | 7 678 | 7 984 | 8 470 |
|
EBITDA Million USD | Released Forecast Spread | 3 959 3 365 17.67% | 3 948 3 498 12.86% | 3 807 3 255 16.94% | 3 589 3 423 4.85% | 3 981 4 110 -3.13% | 4 607 4 587 0.44% | 3 776 4 359 -13.38% | 3 506 | 4 083 | 4 295 | 4 474 | 4 235 | 4 403 | 4 809 | 5 015 |
|
EBIT Million USD | Released Forecast Spread | 3 265 2 739 19.18% | 3 258 2 721 19.75% | 3 114 2 876 8.27% | 2 893 2 825 2.4% | 3 290 3 235 1.71% | 3 921 3 482 12.6% | 3 089 3 098 -0.28% | 3 110 | 3 489 | 3 763 | 3 927 | 3 517 | 3 685 | 4 091 | 4 297 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 053 1 733 18.45% | 956 1 652 -42.12% | 2 168 2 043 6.14% | 1 649 2 068 -20.24% | 2 429 2 355 3.14% | 3 641 2 628 38.56% | 2 078 2 338 -11.11% | 2 236 | 2 618 | 2 861 | 2 908 | ||||
|
Net income Million USD | Released Forecast Spread | 1 614 1 379 17.02% | 1 253 1 335 -6.15% | 1 783 1 605 11.1% | 1 315 1 546 -14.92% | 1 960 1 898 3.24% | 3 052 2 098 45.48% | 2 183 1 819 20% | 1 940 | 2 203 | 2 371 | 2 470 | ||||
|
EPS USD | Released Forecast Spread | 1,29 1,13 14.13% | 1,00 1,08 -7.48% | 1,42 1,19 19.08% | 1,04 1,26 -17.23% | 1,56 1,48 5.12% | 2,43 1,69 43.48% | 1,74 1,54 12.68% | 1,59 | 1,78 | 1,94 | 1,96 | 1,83 | 1,98 | 2,24 | 2,19 |
| Announcement Date | 08/08/24 | 06/11/24 | 11/02/25 | 24/04/25 | 07/08/25 | 30/10/25 | 10/02/26 | - | - | - | - | - | - | - | - |
| Today | Earnings presentation | 13:00 | |
| Today | Earnings presentation | 13:00 | |
| Today | Earnings presentation | 13:30 | |
| Today | Earnings release - Annual 2025 | ~ 14:30 | |
| 06/03/2026 | Information meeting | Day | |
| 06/03/2026 | Earnings presentation | 00:30 | |
| 06/03/2026 | Information meeting | 08:30 | |
| 06/03/2026 | Annual General Meeting | 09:00 | |
| 06/03/2026 | Présentation aux Actionnaires / Analystes | 09:00 | |
| 09/03/2026 | Information meeting | Day |
Past sector events for Gilead Sciences, Inc.
| Today | Earnings release - Annual 2025 | 11:00 | |
| Today | Extraordinary General Meeting | 06:30 | |
| Today | Présentation aux Actionnaires / Analystes | 05:45 | |
| Today | Information meeting | Day | |
| Today | Présentation aux Actionnaires / Analystes | Day | |
| Today | Board of Directors Meeting | Day | |
| 04/03/2026 | Earnings release - Q4 2025 | ~ 21:00 | |
| 04/03/2026 | Earnings release - Q4 2025 | ~ 14:30 | |
| 04/03/2026 | Earnings presentation | 13:30 | |
| 04/03/2026 | Earnings presentation | 13:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- Calendar Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















